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Malignant pleural mesothelioma (MPM) usually shows a diffuse pattern of growth over the pleural surfaces. We 
present an unusual case of MPM that was localized and had 
spread outside the thoracic wall.
CASE REPORT
A 65-year-old man was referred to our hospital because 
of dry cough. He was a never smoker and worked at a chemical 
fiber factory where he was exposed to asbestos for 40 years. 
Physical examination revealed that the skin over the left sub-
clavian area was swollen but without tenderness or redness.
A chest radiograph showed hypolucency on the left side. 
A computed tomographic scan of the chest showed a 7-cm 
diameter tumor on the left anterior chest wall surrounding the 
second rib (Fig. 1). No pleural plaque, effusion, or lymphade-
nopathy was detected. Fluorodeoxyglucose positron emission 
tomographic computed tomographic imaging showed the 
accumulation of fluorodeoxyglucose in the tumor with the 
maximum standardized uptake value of 15.1 without accumu-
lation in any other organ. The diagnosis of MPM, epithelioid 
type, was made from a percutaneous needle-biopsy specimen. 
Thoracoscopic exploration showed that the tumor was covered 
with parietal pleura, and no dissemination was found on the 
pleura. The tumor and the involved first, second, and the third 
ribs were removed with curative intent. The resected specimen 
revealed cubiform tumor cells; some of which were forming 
a papillary tubular structure (Fig. 2A). Immunohistochemical 
analyses demonstrated that the tumor cells were positive for 
calretinin (Fig. 2B), D2–40, Wilms’ tumor 1, thrombomod-
ulin, cytokeratin 5/6, and epithelial membrane antigen, and 
negative for carcinoembryonic antigen (Fig. 2C), thyroid 
transcription factor, and napsin A. The diagnosis was con-
firmed as epithelioid type MPM. Detailed investigation of the 
specimen showed that the parietal pleura was involved with 
tumor cells (Fig. 3), indicating that the tumor originated from 
the parietal pleura. Six months later, he had a local recurrence 
and underwent radiotherapy and systemic chemotherapy.
DISCUSSION
In the current case, a patient presented with MPM that 
localized and spread outside the thoracic wall. The tumor was 
initially suspected to be a soft-tissue neoplasm, osteoblastic 
metastatic tumor, or malignant lymphoma. The pathological 
diagnosis of MPM was determined from a percutaneous needle-
biopsy specimen. Thoracoscopic exploration showed that the 
tumor was covered with parietal pleura without dissemination 
into the pleura, an unusual pattern of MPM progression.
MPM is classified in diffuse MPM or localized 
(LMPM). LMPM is uncommon and characterized by a sharply 
circumscribed tumor of the seromal membranes with the 
microscopic appearance of diffuse malignant mesothelioma, 
but without any evidence of diffuse spread.1 It was formerly 
considered a benign variant of mesothelioma,2 solitary fibrous 
tumor,3 or other neoplasms, but is now defined as having 
the microscopic, histochemical, immunohistochemical, and 
ultrastructural features of diffuse MPM. However, little is 
known about the frequency and clinical behavior of LMPM.
The tumor in the current case was grossly localized in 
the thoracic wall. Detailed pathological analyses showed that 
the parietal pleura were involved with tumor cells, but dif-
fuse pleural spread was not determined; therefore, we regard 
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FIGURE 1. Computed tomographic scan of the chest at 
the time of diagnosis showing (A) coronal and (B) horizontal 
views of a tumor on the left anterior chest wall.
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the current case as LMPM. LMPM should be considered a 
thoracic tumor that is localized and has spread outside the tho-
racic wall.
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FIGURE 2. A, Microscopic examination of the biopsy specimen showed cubiform tumor cells; some of the cells formed papil-
lary tubular structures consistent with malignant mesothelioma (hematoxylin-eosin, 40 ×). B, Immunohistochemical analysis 
indicated positive expression of calretinin (40 ×) and (C) negative expression of carcinoembryonic antigen (40 ×).
FIGURE 3. Microscopic examination of the biopsy specimen 
showed that the parietal pleural was involved with tumor 
cell (arrows), indicating that the tumor originated from the 
parietal pleura.
